Brief: Labcorp Launches First FDA-Cleared Blood Test For Alzheimer's Disease
18/08/2025 14:54
Aug 18 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP LAUNCHES FIRST FDA-CLEARED BLOOD TEST FOR ALZHEIMER'S DISEASE Source text: ID:nPnbH0bDZa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
Brief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says